As of January 22, 2025, Chugai Pharmaceutical (4519.T) has a market cap of $69.96 billion USD. According to our data, Chugai Pharmaceutical is ranked No.280 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 22, 2025 | $69.96 B |
-5.52%
|
Dec 30, 2024 | $74.04 B |
31.95%
|
Dec 29, 2023 | $56.11 B |
61.35%
|
Dec 30, 2022 | $34.78 B |
-7.79%
|
Dec 30, 2021 | $37.71 B |
-30.82%
|
Dec 30, 2020 | $54.52 B |
66.69%
|
Dec 30, 2019 | $32.71 B |
59.84%
|
Dec 31, 2018 | $20.46 B |
11.40%
|
Dec 29, 2017 | $18.37 B |
74.15%
|
Dec 30, 2016 | $10.55 B |
-19.68%
|
Dec 30, 2015 | $13.13 B |
44.12%
|
Dec 30, 2014 | $9.11 B |
29.57%
|
Dec 30, 2013 | $7.03 B |
43.86%
|
Dec 28, 2012 | $4.89 B |
33.52%
|
Dec 30, 2011 | $3.66 B |
-12.14%
|
Dec 30, 2010 | $4.17 B |
-12.14%
|
Dec 30, 2009 | $4.74 B |
3.29%
|
Dec 30, 2008 | $4.59 B |
9.92%
|
Dec 28, 2007 | $4.18 B |
-33.80%
|
Dec 29, 2006 | $6.31 B |
-1.72%
|
Dec 30, 2005 | $6.42 B |
51.00%
|
Dec 31, 2004 | $4.25 B |
11.10%
|
Dec 31, 2003 | $3.83 B |
38.43%
|
Dec 31, 2002 | $2.76 B |
-24.62%
|
Dec 31, 2001 | $3.67 B |
-19.29%
|
Dec 29, 2000 | $4.54 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Chugai Pharmaceutical
4519.T
|
$69.96 B |
0.455 B
|
Japan
|
Sanofi
SNY
|
$128.49 B |
0.002 M
|
France
|
Roche
ROG.SW
|
$243.91 B |
38.073 B
|
Switzerland
|
AstraZeneca
AZN
|
$211.43 B |
0.005 M
|
UK
|
Bristol-Myers Squibb
BMY
|
$115.97 B |
0.003 M
|
USA
|
Merck
MRK
|
$242.59 B |
0.007 M
|
USA
|
Gilead Sciences
GILD
|
$115.25 B |
-0.604 B
|
USA
|
Sanofi
SNY
|
$128.49 B |
0.002 M
|
France
|
Novartis
NVS
|
$197.43 B |
0.007 M
|
Switzerland
|
Bayer
BAYN.DE
|
$21.48 B |
-0.001 M
|
Germany
|
Eli Lilly
LLY
|
$676.92 B |
0.020 M
|
USA
|
Johnson & Johnson
JNJ
|
$347.78 B |
-0.005 M
|
USA
|
Amgen
AMGN
|
$146.94 B |
0.008 M
|
USA
|
Market Cap | = | 4519.T Stock Price | * | 4519.T Shares Outstanding |
= | $42.51 | * | 1.65 B | |
= | $69.96 B |